Dr. Ibrahim Ebada Sadek, MD

Dr. Sadek practices at Florida Cancer Specialists & Research Institute - Cape Coral Cay West in Cape Coral, Florida.

Dr. Sadek's NPI, 1457672685, was assigned on June 22, 2010. Dr. Sadek graduated from Suez Canal University in 2001. Dr. Sadek holds Florida license ME153800.

Dr. Sadek's primary practice is Florida Cancer Specialists & Research Institute - Cape Coral Cay West, at 1708 Cape Coral W Pkwy, Cape Coral, FL 33914 in Lee County. The practice phone is (239) 541-4633.

Dr. Sadek's primary practice is Florida Cancer Specialists & Research Institute - Cape Coral Cay West in Cape Coral, Florida. Dr. Sadek is also affiliated with UF Health Spanish Plaines Hospital. The medical group on file is Florida Cancer Specialists & Research Institute. Dmand AI also links Dr. Sadek to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sadek practices, 3 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dr. Sadek's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Sadek is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Sadek's licenses on file in 6 states: Florida, Indiana, Wisconsin, Iowa, Georgia and Michigan.

Dmand AI lists breast cancer, chronic anemia, chronic leukemia, colorectal cancer, immune deficiency disease, lung cancer, lymphoma and multiple myeloma among the conditions Dr. Sadek treats.

CMS data shows 174,762 Medicare services from Dr. Sadek across 62 procedure codes in 2024, for 1,560 Medicare patients. Medicare paid $1,978,517 for them.

CMS counts 1,560 Medicare patients who saw Dr. Sadek in 2024. The largest group is 75 to 84, with 821 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 4% are also on Medicaid. Their average risk score is 2.29, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sadek's median patient age at 76, with 55% women.

In 2024, Dr. Sadek wrote 1,234 Medicare Part D claims for 323 patients. 72% of them were for generic drugs. CMS names the drug for 990 of them, across 33 drugs with 11 or more claims each, at $3,727,478 in total drug cost. In 2023, CMS named 597 claims across 22 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Sadek for performance year 2024, reported as part of a group. Dr. Sadek accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Sadek as offering telehealth.

Dmand AI links 4 papers to Dr. Sadek, published from 2009 to 2017. The most frequent topics are Amyloidosis. Dr. Sadek's most frequent co-authors are Morie A. Gertz, MD, Zhonglin Hao, MD, PhD and Suzanne R. Hayman, MD.

CMS Open Payments shows 618 general payments to Dr. Sadek from 65 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 81% of the total. Takeda Pharmaceuticals U.S.A., Inc. paid the most, $1,492.

Dr. Sadek graduated from Suez Canal University in 2001.

Dr. Sadek is in network with 20 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.